Newsroom

シドニー--(BUSINESS WIRE)--（ビジネスワイヤ） -- オーテル・エナジーは、6月9日シドニーで「Powering the Future – Autel 2026 EV Charging Innovation Seminar」を開催し、業界パートナー、顧客、エコシステム関係者が集まり、オーストラリアにおけるインテリジェントEV充電とエネルギー・インフラの未来について議論しました。 セミナーは、オーテルの会長 李紅京（Frank Li）によるビデオあいさつで開幕しました。同氏は、「よりスマートで、より高度に接続された持続可能な充電インフラ・エコシステムの構築」に向けたオーテルの取り組みを改めて表明しました。 オーテルは、充電インフラの基準を再定義する、オーストラリア市場向けの複数のイノベーションを同国で初公開しました。「DH120 DC充電器」は、キャビネットの奥行き25cmの超薄型設計で、設置面積は0.16m2未満です。最大97%の効率で、2台の車両を同時に充電できます。また、制御式の力率調整技術も紹介しました。これは無効電力補償機能を備えたオーストラリア初の充電ソリ...

GENEVA--(BUSINESS WIRE)--The Wyss Center for Bio and Neuroengineering in Geneva is pleased to announce the appointment of Dr. Tracy Laabs as Director, effective July 1st 2026. Dr. Laabs succeeds Prof. Dr. Erwin Böttinger, who leaves behind a fundamentally transformed organization: one that no longer just pursues breakthrough science but systematically turns it into ventures that reach patients. Since joining the Wyss Center as Director in April 2023, Prof. Böttinger brought a bold vision: to ev...

OTTAWA, Ontario--(BUSINESS WIRE)--Porter Airlines is inaugurating service between Ottawa International Airport (YOW) and Deer Lake Regional Airport (YDF) today, becoming the only airline to connect the two destinations with non-stop flights. The seasonal route starts with four weekly roundtrips and ends in early September. The Embraer E195-E2 aircraft used for these flights carries up to 132 passengers, and with a two-by-two configuration, there are no middle seats on any flight. All of Porter’...

OTTAWA--(BUSINESS WIRE)--Porter Airlines inaugure aujourd’hui le service entre l’aéroport international d’Ottawa (YOW) et l’aéroport régional de Deer Lake (YDF), devenant ainsi la seule compagnie aérienne à relier les deux destinations par des vols sans escale. Cet itinéraire saisonnier commence par quatre allers-retours par semaine et sera offert jusqu’au début septembre. L’aéronef Embraer E195-E2 utilisé pour ces vols peut transporter jusqu’à 132 passagers. Grâce à une configuration deux par...

LONDON--(BUSINESS WIRE)--Netflix is forecast to reach nearly 400 million subscribers worldwide by the end of 2031, reinforcing its position as the world’s leading subscription streaming platform despite growing consolidation across the industry. New forecasts from Omdia presented at NEM Dubrovnik 2026 indicate that scale, profitability and audience reach will increasingly shape the next phase of streaming competition. Omdia’s forecasts highlighted Netflix's continued expansion despite increasin...

SUNNYVALE, Calif.--(BUSINESS WIRE)--Coram AI raises $35M Series B to power its AI-native physical security platform, helping organizations identify risks earlier and investigate faster....

BOTHELL, Wash.--(BUSINESS WIRE)--Immunome, Inc. (Nasdaq: IMNM), a biotechnology company committed to developing first-in-class and best-in-class targeted cancer therapies, today announced that the first patient has been dosed in the Phase 1, first-in-human trial of IM-1617, a potential first-in-class ADC directed at an undisclosed solid tumor target and incorporating HC74, Immunome’s proprietary TOP1 inhibitor payload. “The first patient dosed with IM-1617 is a significant milestone for Immunom...

TORONTO--(BUSINESS WIRE)--NeuPath Health Inc. (TSXV:NPTH), (“NeuPath” or the “Company”), operates one of Canada’s largest networks of community-based, multidisciplinary medical facilities focused on the assessment and treatment of chronic pain, musculoskeletal/back pain, sports medicine and other pain medical services, today announced the voting results from its Annual General and Special Meeting of Shareholders (the “Meeting”) held on June 10, 2026 and the grant of restricted share units (“RSU...

LONDON--(BUSINESS WIRE)--Silence Therapeutics plc (Nasdaq: SLN), a global clinical-stage biotechnology company developing novel siRNA (short interfering RNA) therapies, today presented follow-up and quality-of-life data from the Phase 1 SANRECO study evaluating divesiran, a first-in-class siRNA therapy targeting TMPRSS6, in 21 phlebotomy-dependent patients with polycythemia vera (PV) at the European Hematology Association (EHA) 2026 Annual Congress. Divesiran data presented at EHA show improvem...

MINNEAPOLIS--(BUSINESS WIRE)--Yukon Partners is pleased to announce the promotion of Adam Moorse to Director....